Active Ingredient (In Each Extended-Release Bi-Layer Tablet)
Guaifenesin 1200 mg
The following Structured Product Label (SPL) was submitted to the FDA by Yet Health Group Llc for the product Expectorant Guaifenesin Extended-release (NDC 81179-007). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each extended-release bi-layer tablet), purpose, uses, warnings, otc - keep out of reach of children, directions, other information, inactive ingredients, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Guaifenesin 1200 mg
Expectorant
Do not use
Ask a doctor before use if you have
Stop use and ask a doctor if
If pregnant or breast-feeding, ask a health professioal before use.
Keep out of reach of children. In case of overdose, get medical help or call a Poison Control Center (1-800-222-1222) right away.
carbomer homopolymer type B, hypromellose, magnesium stearate, microcrystalline cellulose, sodium starch glycolate.
call 1-844-735-0202
* Please review the disclaimer below.